The Improving and Accelerating Translation Grant Program has announced its applications to support investigators at Australian and international research institutions working to overcome barriers to translating promising discoveries into effective MND treatments and improve the likelihood of successful clinical trials. Projects may address disease heterogeneity, relevant preclinical models, reliable disease biomarkers, drug delivery into the
Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members: